News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

StemPar Sciences Secures Initial Funding For Its Novel Cancer Metabolism Drugs


1/2/2013 9:24:54 AM

San Francisco, CA, Jan. 2, 2013 (GLOBE NEWSWIRE) -- Privately held StemPar Sciences, Inc. today announced an initial investment from Troika Venture Capital, a multi-profile international venture capital firm. In addition, Troika has committed to participate in future StemPar financings.

Read at GlobeNewswire

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES